Insights
Before You Choose a PBM, do the Math
Cost is black & white Price alone isn’t. Your PBM must also control utilization or you’ll be seeing red.
Five Initial Evaluation Issues That May Delay Return to Work
When there’s a return to work delay, practitioners often look for problems that occurred during the course of treatment. However, as Mariellen Blue, Genex’s National Director of Case Management Services, tells us in today’s Inside Workers’ Comp, you may have to go back a little further in the recovery plan to find the answer. Check out the five reasons why the initial evaluation may be the culprit.
The Impact of Tariffs on the Automotive Claims Industry
There has been a significant amount of press coverage surrounding the potential imposition of a 25 percent tariffs on automobiles and auto parts imported to the United States from countries that have previously received “most favored nation” status, incurring tariffs of only 2.5 percent. The proposed tariff increase emerged as a response from the Trump administration to increasing globalization of the auto industry.
KPI Spotlight: Percentage of Repair for Individual Part Types
In our recent article, “Mitchell Collision Repair Industry Data: Q2 2018”, we discussed the importance of monitoring the overall percentage of parts repaired. While this is an important step to help ensure the correct decision-making behaviors are being put into practice by appraisers in the field, it is the first of many. The next step to improving performance in regards to overall percentage of parts repaired is to look at repair percentages for individual major component parts.
A New Era of Performance Management
As McKinsey and Company stated in their 2017 study on performance management, “What gets measured, gets done.”1 Performance management is a critical aspect of success in any field of business, and this is especially true in the world of auto physical damage claims. Success comes in many forms in the claims industry, from managing costs to producing proper and safe repairs.
StateWatch: Fall 2018
11 MIN READ
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the services Genex provides.
StateWatch: Fall 2018
11 MIN READ
The FDA has approved a non-opioid, percutaneous electrical nerve field stimulator device as an aid to reduce opioid withdrawal symptoms during detoxification.